COVID-19

September 17, 2021

GSK Seeks Approval for COVID-19 Drug in Japan

GlaxoSmithKline PLC has filed for Japanese government approval for its COVID-19 drug to treat patients with mild to moderate symptoms. If approved, the antibody drug, sotrovimab, would be Japan’s fifth recognized treatment for COVID-19 patients. The company, a Platinum member of the BCCJ, is seeking fast-track approval. The drug, which works to protect cells from …
Read more
Feature News Image
news thumbnail

September 17, 2021

GSK Seeks Approval for COVID-19 Drug in Japan

GlaxoSmithKline PLC has filed for Japanese government approval for its COVID-19 drug to treat patien ...

Read more
news thumbnail

August 26, 2021

BCCJ Vaccination Accelerator programme – thank you

For the past two months, the British Chamber of Commerce in Japan (BCCJ) team has been running a Vac ...

Read more
news thumbnail

August 23, 2021

Travel Advice, UK – Japan

Entry rules in response to coronavirus (COVID-19) This page is a snapshot of the UK government’s u ...

Read more
news thumbnail

July 1, 2021

Securing your COVID-19 Vaccination in Japan

Unsure of when and how you / your team / family members will receive your first COVID-19 vaccination ...

Read more
news thumbnail

June 25, 2021

BCCJ Secures Vaccinations for 1050 Members

This week, the BCCJ team has been working around the clock to secure COVID-19 vaccinations for membe ...

Read more
news thumbnail

June 21, 2021

BCCJ Vaccinations Update as of June 21

*UPDATE: The BCCJ team is now supporting members to access COVID-19 vaccinations / around 250 member ...

Read more
news thumbnail

June 20, 2021

COVID-19 Vaccinations in Japan – RESOURCES

GENERAL INFORMATION The Japanese Government’s Ministry of Health, Labour and Welfare COVID-19 ...

Read more
news thumbnail

June 11, 2021

Vaccinations in Japan – Can you introduce doctors / medical professionals?

This week the BCCJ team have been actively scoping the opportunity to support Japan’s COVID-1 ...

Read more